Shares of Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report) traded up 9.1% on Tuesday . The company traded as high as GBX 1.80 ($0.02) and last traded at GBX 1.80 ($0.02). 1,744,599 shares traded hands during trading, an increase of 4% from the average session volume of 1,670,021 shares. The stock had previously closed at GBX 1.65 ($0.02).
Cizzle Biotechnology Stock Up 11.4 %
The stock has a market cap of £7.29 million, a price-to-earnings ratio of -183.80 and a beta of 0.38. The stock has a 50 day simple moving average of GBX 1.79 and a 200 day simple moving average of GBX 1.84.
About Cizzle Biotechnology
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021.
Featured Stories
- Five stocks we like better than Cizzle Biotechnology
- What is the Nikkei 225 index?
- Merck: 4 No-Brainer Reasons to Buy This Dip
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- How to Calculate Options Profits
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
